phenylalanylarginine has been researched along with ng-nitroarginine methyl ester in 1 studies
| Studies (phenylalanylarginine) | Trials (phenylalanylarginine) | Recent Studies (post-2010) (phenylalanylarginine) | Studies (ng-nitroarginine methyl ester) | Trials (ng-nitroarginine methyl ester) | Recent Studies (post-2010) (ng-nitroarginine methyl ester) |
|---|---|---|---|---|---|
| 17 | 0 | 10 | 12,640 | 117 | 2,342 |
| Protein | Taxonomy | phenylalanylarginine (IC50) | ng-nitroarginine methyl ester (IC50) |
|---|---|---|---|
| Neutrophil elastase | Homo sapiens (human) | 2.7 | |
| Nitric oxide synthase, endothelial | Homo sapiens (human) | 2.1 | |
| Nitric oxide synthase, brain | Homo sapiens (human) | 1.1167 | |
| Nitric oxide synthase, inducible | Mus musculus (house mouse) | 2.6 | |
| Nitric oxide synthase, inducible | Homo sapiens (human) | 8 | |
| Collagenase 3 | Homo sapiens (human) | 2.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, T; Kagebayashi, T; Kino, K; Kontani, N; Mizushige, T; Ohinata, K; Yamada, Y | 1 |
1 other study(ies) available for phenylalanylarginine and ng-nitroarginine methyl ester
| Article | Year |
|---|---|
Novel CCK-dependent vasorelaxing dipeptide, Arg-Phe, decreases blood pressure and food intake in rodents.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cholecystokinin; Dipeptides; Eating; Enteroendocrine Cells; Enzyme Inhibitors; Indomethacin; Male; Mesenteric Arteries; Mice; Mice, Inbred Strains; NG-Nitroarginine Methyl Ester; Nitric Oxide; Proglumide; Prostaglandins; Rats; Rats, Inbred SHR; Receptors, Cholecystokinin; Vasodilator Agents | 2012 |